Join to view full profile
P.O.Box 44558Kamuela, HI 96743
Phone+1 714-392-1971
Fax+1 714-276-2081
Dr. Barth is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Neil Barth is an oncologist based in Kamuela, HI, specializing in breast cancer, cancer genetics, cancer risk assessment, and hematologic oncology. He completed his education and training at Los Angeles County-Harbor-UCLA Medical Center and The University of Toledo College of Medicine. Dr. Barth has held leadership roles, including President at Genomics Institute and Chief Medical Officer at Veracyte Inc. His clinical experience extends to immunotherapy, melanoma, and health outcomes research. Dr. Barth has contributed to various publications, with several articles extensively cited in reputable journals. His accolades include CMS Meaningful Use Stage 1 Certification, Most Compassionate Doctor, Super Doctor, and Top MD.
Education & Training
Los Angeles County-Harbor-UCLA Medical Center 1Fellowship, Hematology and Medical Oncology, 1981 - 1983- Los Angeles County-Harbor-UCLA Medical Center 1Fellowship, Hematology and Medical Oncology, 1980 - 1981
- Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1978 - 1980
- Los Angeles County-Harbor-UCLA Medical CenterInternship, Transitional Year, 1977 - 1978
The University of Toledo College of MedicineClass of 1977
Certifications & Licensure
HI State Medical License 2015 - 2028
CA State Medical License 1978 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc, 2012
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011
- Most Compassionate Doctor American Registry
Publications & Presentations
PubMed
- 107 citationsUse of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation studyGanesh Raghu, Kevin R. Flaherty, David J. Lederer, David A. Lynch, Thomas V. Colby
The Lancet. Respiratory Medicine. 2019-06-01 - 260 citationsPerformance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid NodulesKepal N. Patel, Trevor E. Angell, Joshua E. Babiarz, Neil M. Barth, Thomas Blevins
JAMA Surgery. 2018-09-01 - 21 citationsIdentification of usual interstitial pneumonia pattern using RNA-Seq and machine learning: challenges and solutions.Yoonha Choi, Tiffany Ting Liu, Daniel G. Pankratz, Thomas V. Colby, Neil M. Barth
BMC Genomics. 2018-05-09
Journal Articles
- Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid NodulesMichael H Shanik, Paul W Ladenson, Peter M Sadow, Julie A Sosa, Ronald A Ghossein, S Thomas Traweek, Neil M Barth, Kepal N Patel, Trevor E Angell, Richard T Kloos, Vir..., JAMA
Press Mentions
NHCH Welcomes New OncologistMay 23rd, 2018
Veracyte Announces Presentation of New Clinical Utility Data at CHEST 2017 Showing Percepta Classifier Reduces Invasive Procedures in Lung Cancer DiagnosisNovember 1st, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
